- Home
- RGNT vs KNRX Comparison
RGNT vs KNRX Comparison
Compare RGNT & KNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNT | KNRX |
|---|---|---|
| Founded | 2004 | 2009 |
| Country | Israel | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3M | 10.9M |
| IPO Year | 2022 | 2023 |
Fundamental Metrics
Financial Performance| Metric | RGNT | KNRX |
|---|---|---|
| Price | $1.86 | $0.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.5K | ★ 4.8M |
| Earning Date | 05-05-2026 | 06-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.23 | $0.30 |
| 52 Week High | $15.50 | $3.45 |
Technical Indicators
Market Signals| Indicator | RGNT | KNRX |
|---|---|---|
| Relative Strength Index (RSI) | 42.60 | 40.06 |
| Support Level | $1.82 | $0.33 |
| Resistance Level | $2.27 | $0.49 |
| Average True Range (ATR) | 0.11 | 0.03 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 31.71 | 12.79 |
Price Performance
Historical ComparisonAbout RGNT Regentis Biomaterials Ltd. Ordinary Shares
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.
About KNRX KNOREX LTD. Class A Ordinary Shares
Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. The company's product, Knorex XPOSM, is a self-service, enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications.